pembrolizumabgemcitabinesplit-dose cisplatinimmunotherapyLynch syndromestage I colon cancerLS
… cancer. An initial attempt to obtain an insurance approval for pembrolizumab given LS and context of deficient mismatch repair was unsuccess…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: split-dose cisplatin ×
split-dose cisplatin
This drug is selected. Its supporting articles are shown below.